African American Men With Advanced Prostate Cancer May Gain Significant Benefit From Provenge (Sipuleucel-T)
A subgroup analysis of the phase III trials of Provenge (Sipuleucel-T) suggests that there might be a dramatic role for Provenge in African-American men who have advanced prostate cancer that has become castration-resistant (mCRPC). The [...]
The Current Status of the Debate on Prostate Cancer Screening
All of us in the prostate cancer world know that the U.S. Preventive Services Task Force (USPTF) has announced its recommendation against routine PSA screening for men. There remains much debate and unhappiness in both [...]
Can Acupuncture Relieve Cancer Related Fatigue? -Probably
Cancer related fatigue (CRF) is a common problem suffered by many cancer survivors, including men with advanced prostate cancer. Whether the fatigue is a result of the cancer or of the treatment doesn’t really matter. [...]
A Weed Killer Drug From Mediterranean Kills Prostate Cancer Tumor Cells
Johns Hopkins Kimmel Cancer Center along with Danish researchers have announced the development of a novel, investigational anticancer drug (G202) that has been described as a molecular grenade that targets cancer cells. The drug is [...]
New Sites Added for the Early/Expanded Access Program for Enzalutamide (MDV3100)
It has just been announced that there are now two new additional sites added to the Early/Expanded Access Program for Enzalutamide (MDV3100). The program is technically a clinical trial designed to monitor MDV-3100’s safety in [...]
A Possible Provenge Private Insurance Hitch In Men with Advanced Prostate Cancer
At a recent meeting that I attended it was reported by a nurse that one of her patients with advanced prostate cancer with only a PSA recurrence and lymph node involvement on a scan was [...]